Artwork

Innhold levert av The Cardio Ed Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Cardio Ed Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Abelacimab for prevention of venous thromboembolism after knee replacement. NEJM 2021

5:57
 
Del
 

Manage episode 307826820 series 2935001
Innhold levert av The Cardio Ed Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Cardio Ed Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
#Abelacimab for #VenousThromboembolism prevention after #TotalKneeReplacement, published in July 2021 edition of #NEJM. #Abelacimab is #MonoclonalAntibody against #Factor XI, a key component of #intrinsicCoagulationPathway. It has been used in prevention of Venous Thromboembolism after Total Knee Replacement and compared to #Enoxaparin. In this study published in #NEJM or the #NewEnglandJournalOfMedicine Abelacimab has been used in 4 doses and its safety and efficacy has been studied. Abelacimab blocks the intrinsic clotting pathways and may be a useful drug in our armamentarium of venous thromboembolism prevention after orthopaedic surgeries like total knee replacement. To know about Abelacimab, intrinsic coagulation pathway inhibition and venous thromboembolism prevention after Total knee replacement watch this video. Follow #Cardio-Ed for more such content on recent advances, recent guidelines and recent articles in the field of cardiology. https://youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw
  continue reading

34 episoder

Artwork
iconDel
 
Manage episode 307826820 series 2935001
Innhold levert av The Cardio Ed Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Cardio Ed Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
#Abelacimab for #VenousThromboembolism prevention after #TotalKneeReplacement, published in July 2021 edition of #NEJM. #Abelacimab is #MonoclonalAntibody against #Factor XI, a key component of #intrinsicCoagulationPathway. It has been used in prevention of Venous Thromboembolism after Total Knee Replacement and compared to #Enoxaparin. In this study published in #NEJM or the #NewEnglandJournalOfMedicine Abelacimab has been used in 4 doses and its safety and efficacy has been studied. Abelacimab blocks the intrinsic clotting pathways and may be a useful drug in our armamentarium of venous thromboembolism prevention after orthopaedic surgeries like total knee replacement. To know about Abelacimab, intrinsic coagulation pathway inhibition and venous thromboembolism prevention after Total knee replacement watch this video. Follow #Cardio-Ed for more such content on recent advances, recent guidelines and recent articles in the field of cardiology. https://youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw
  continue reading

34 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett